Machine learning prediction for AML based on 3D genome selected circRNA.

Journal: NPJ systems biology and applications
Published Date:

Abstract

Acute myeloid leukemia (AML) is a clinically aggressive hematologic malignancy driven by complex genetic and epigenetic aberrations. Circular RNAs (circRNAs), characterized by covalently closed structures and exceptional stability, have emerged as promising diagnostic biomarkers. However, existing circRNA-based predictive models largely depend on differential expression, overlooking the potential impact of higher-order chromatin organization on circRNA formation and function. Here, we propose a machine learning framework that integrates three-dimensional (3D) genome architecture to refine circRNA selection for AML prediction. By mapping 9,565 circRNAs onto a 3D chromatin model reconstructed from Hi-C data, we analyzed their spatial clustering and biological pathway enrichment. Eighteen pathways exhibited significant 3D aggregation of circRNAs, enabling radial stratification based on nuclear localization. Five circRNA panels were designed using complementary strategies combining expression, pathway, and spatial features. Cross-validation and external validation across six machine learning algorithms showed that the panel derived from the fifth radial layer (Panel-3DG-Radius5) achieved the most robust and consistent performance (ROC-AUC > 0.99). Integrating 3D genomic context reduced feature collinearity while enhancing biological interpretability. Overall, our study establishes a 3D genome-informed paradigm for circRNA biomarker discovery, demonstrating that spatial genome organization can substantially improve the precision and robustness of AML predictive modeling.

Authors

  • Zhangli Yuan
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
  • Wenqian Yan
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
  • Ruoyao Wang
    Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Shanshan Yin
    School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
  • Chongchen Pang
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
  • Xinyuan Ren
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
  • Wenchang Duan
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
  • Mika Torhola
    Atostek Oy, Hermiankatu 3 A, Tampere, Finland.
  • Klaus Förger
    Atostek Oy, Hermiankatu 3 A, Tampere, Finland.
  • Henna Kujanen
    Atostek Oy, Hermiankatu 3 A, Tampere, Finland.
  • Yixin Zhang
    Beijing Institute of Radiation Medicine, Beijing, China.
  • Haoyan Chen
    Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hui Shi
    Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Yuqing Lou
  • Hao Li
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Guang He
    Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China. [email protected].
  • Yi Shi
    College of Food Science and Engineering, Nanjing University of Finance and Economics/Collaborative Innovation Center for Modern Grain Circulation and Safety, Nanjing 210023, People's Republic of China.

Keywords

No keywords available for this article.